Drug Shortage Report for LMD 10% IN DEXTROSE 5%
| Report ID | 140054 |
| Drug Identification Number | 00224235 |
| Brand name | LMD 10% IN DEXTROSE 5% |
| Common or Proper name | LMD 10 % In Dextrose 5% |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE DEXTRAN |
| Strength(s) | 5% 10% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 12 x 500mL bag |
| ATC code | B05AA |
| ATC description | BLOOD AND RELATED PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-08-02 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2022-04-04 |
| Shortage status | Resolved |
| Updated date | 2022-04-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-04-05 | French | Compare |
| v4 | 2022-04-05 | English | Compare |
| v3 | 2021-08-03 | English | Compare |
| v2 | 2021-05-28 | French | Compare |
| v1 | 2021-05-28 | English | Compare |
Showing 1 to 5 of 5